Display options
Share it on
Full text links
Silverchair Information Systems Free PMC Article

Biochem J. 1992 Dec 01;288:613-7. doi: 10.1042/bj2880613.

Microtubule-independent choleresis and anti-cholestatic action of tauroursodeoxycholate in colchicine-treated rat liver.

The Biochemical journal

T Nakai, K Katagiri, M Hoshino, T Hayakawa, T Ohiwa

Affiliations

  1. First Department of Internal Medicine, Nagoya City University, Medical School, Japan.

PMID: 1361125 PMCID: PMC1132054 DOI: 10.1042/bj2880613
Free PMC Article

Abstract

In order to cast light on the anti-cholestatic and cytoprotective properties of ursodeoxycholic acid (UDCA), intrahepatic transport and secretion of bile salts and biliary phospholipids were investigated by using isolated perfused livers from colchicine-pretreated rats. Administration of taurocholic acid (TCA) after colchicine pretreatment induced marked cholestasis. Tauroursodeoxycholic acid (TUDCA) treatment, in contrast, was associated with maintenance of bile flow, with excretion rates of bile acids and phospholipids similar to those in control animals. Furthermore, TCA-induced cholestasis in colchicine-treated rat livers was clearly decreased by co-administration of TUDCA. Although simultaneous addition of UDCA also showed slight improvement, with or without taurine pre-treatment, biliary bile-salt analysis also showed that cholestasis was markedly remitted as the excretion of taurine-conjugated UDCA was increased. The results suggest that the cytoprotective and anti-cholestatic effects of TUDCA may be linked to action at the intrahepatocyte level, represented by mild detergent effects on organelle lipids and preservation of intracellular transport even under microtubule-dysfunctional conditions. In addition, it was indicated that cytoprotective effects of UDCA may also be exerted after its conjugation with taurine inside hepatocytes.

Similar articles

References

  1. Am J Physiol. 1985 Apr;248(4 Pt 1):G407-17 - PubMed
  2. Lancet. 1987 Apr 11;1(8537):834-6 - PubMed
  3. Biochim Biophys Acta. 1986 Mar 21;876(1):1-12 - PubMed
  4. J Clin Invest. 1974 Jun;53(6):1512-7 - PubMed
  5. Biochem Biophys Res Commun. 1972 May 26;47(4):685-91 - PubMed
  6. J Lipid Res. 1967 Sep;8(5):486-93 - PubMed
  7. Biochem J. 1982 Oct 15;208(1):153-7 - PubMed
  8. Nihon Shokakibyo Gakkai Zasshi. 1984 Nov;81(11):2821-5 - PubMed
  9. J Lipid Res. 1982 Jan;23(1):70-80 - PubMed
  10. Life Sci. 1982 Feb 7;30(6):515-23 - PubMed
  11. Gastroenterology. 1978 Jan;74(1):93-100 - PubMed
  12. J Cell Biol. 1975 Oct;67(1):237-43 - PubMed
  13. Gastroenterology. 1990 Feb;98(2):424-8 - PubMed
  14. Lancet. 1987 Aug 15;2(8555):398-9 - PubMed
  15. J Lipid Res. 1988 Feb;29(2):144-56 - PubMed
  16. Dig Dis Sci. 1985 Jul;30(7):642-9 - PubMed
  17. Fed Proc. 1974 Feb;33(2):158-66 - PubMed
  18. Biochem J. 1984 Sep 15;222(3):631-7 - PubMed
  19. Biochem J. 1984 Jun 15;220(3):723-31 - PubMed
  20. Biochem J. 1983 Nov 15;216(2):409-14 - PubMed
  21. FEBS Lett. 1980 Nov 3;120(2):278-82 - PubMed
  22. J Clin Invest. 1975 Jan;55(1):105-14 - PubMed
  23. Gastroenterology. 1991 Jan;100(1):203-11 - PubMed
  24. Life Sci. 1990;47(26):2421-8 - PubMed
  25. Am J Physiol. 1987 Mar;252(3 Pt 1):G339-44 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources